Domains targeting keyword prescribing information

Learn about VONVENDI for adults with VWD. Please see Detailed Important Risk Information and full Prescribing Information.

See information about basal insulin & the long-acting insulin from Levemir®. Read Important Safety & Prescribing Info from the Levemir® HCP Website.

ADCETRIS® (brentuximab vedotin) injection information for patients. Please see Important Safety and Prescribing Information, including BOXED WARNING.

Discover Welchol®, which may help patients with type 2 diabetes lower high blood sugar and “bad” cholesterol levels. See Safety & Prescribing Information.

Learn about AFSTYLA, a Factor VIII therapy that provides long-lasting bleed protection for people with hemophilia A. Also explore how to get a free 30-day trial.

Learn more about FYCOMPA, a treatment for partial-onset seizures and PGTC (grand mal) seizures. View Important Safety Information, Boxed Warning and Prescribing Information.

EMVERM (mebendazole) 100-mg chewable tablets are a pinworm treatment. Learn more about EMVERM. Only your doctor can determine if EMVERM is right for you.

Learn about ADVATE. Please see the ADVATE Detailed Important Risk Information and full Prescribing Information.

Learn about Synthroid® (levothyroxine sodium tablets, USP) and click for full safety and prescribing information, including important safety information.

Learn more about INGREZZA—the first FDA-approved treatment for adults with tardive dyskinesia (TD).

Credible, relevant, and proven information on Duromine 30mg pills. Guide / Manual for treatment of persons who suffer from overweight & obesity.

Please see Important Safety Information and full Prescribing Information, including Boxed Warning, and Medication Guide.

Learn about PARAGARD—the only hormone-free IUD that’s over 99% effective. It helps prevent pregnancy for up to 10 years, but your HCP can remove it at any time. Please see Important Safety Information and full Prescribing Information on this website.

Learn about living with alpha-1 antitrypsin deficiency and Zemaira therapy. See full safety and prescribing information.

The Official Website for VELCADE® (bortezomib).

Information for patients about an FDA-approved topical prescription medicine for Stage IA & IB mycosis fungoides–type cutaneous t-cell lymphoma. Find important safety information medication guide and prescribing information.

Learn about Welchol® a treatment indicated to treat patients with type 2 diabetes by lowering A1C and LDL-C levels. See Safety & Prescribing Information.

Get information on INGREZZA safety, dosing, and efficacy to help support your adult patients with TD. See safety and product information.

Learn about VALSTAR® (valrubicin), including safety and side effects, features and risks, and full prescribing information

Learn about AMRIX® (Cyclobenzaprine Hydrochloride Extended‐Release Capsules) for the treatment of muscle spasm due to acute, painful musculoskeletal conditions. AMRIX is a prescription medicine used along with rest and physical therapy to help treat muscle spasm due to acute, painful musculoskeletal problems. AMRIX should only be used for up to 2 or 3 weeks. It is not known if AMRIX is effective when used for longer periods. It is not known if AMRIX is safe and effective in children. Do not take AMRIX if you: • are allergic to cyclobenzaprine or any of the components of AMRIX. Talk to your healthcare provider or get medical help right away if you have symptoms of an allergic reaction such as difficulty breathing, hives, swelling of your face or tongue, or itching • are taking certain antidepressants known as monoamine oxidase (MAO) inhibitors, or it has been 14 days or less since you stopped taking a MAO inhibitor. Ask your healthcare provider or pharmacist for a list of these medicines if you are not sure • have had a recent heart attack • have heart rhythm problems (arrhythmias) • have heart failure • have an overactive thyroid (hyperthyroidism). Talk to your healthcare provider before taking this medicine if you have any of the conditions listed above. You should not drink alcohol until you know how AMRIX affects you. Taking AMRIX with alcohol or other medicines that depress your central nervous system can slow your thinking and physical response times. Do not drive, operate machinery, or do other dangerous activities until you know how AMRIX affects you. AMRIX may cause serious side effects that may lead to heart attack or stroke. Call your healthcare provider immediately or go to the nearest hospital emergency room if you have: • irregular or abnormal heartbeats (arrhythmias) • fast heartbeat (tachycardia). Serotonin syndrome is a serious medical condition that may happen when AMRIX is taken with certain other medicines. Call your healthcare provider right away or go to the nearest hospital emergency room if you become severely ill and have some or all of these symptoms: • agitation, hallucinations, coma, or other changes in mental status • coordination problems or muscle twitching (overactive reflexes) • fast heartbeat, high or low blood pressure • sweating or fever • nausea, vomiting, or diarrhea • muscle stiffness or tightness. The most common side effects of AMRIX include dry mouth, dizziness, fatigue, constipation, nausea, upset stomach, and drowsiness. Tell your healthcare provider if you get any side effect that bothers you or that does not go away. These are not all the possible side effects of AMRIX. For more information, talk to your healthcare provider or pharmacist. Please see the Patient Information Leaflet within the accompanying Full Prescribing Information.

SUBOXONE Film along with counseling and psychosocial support may help you—or someone you care about—manage opioid dependence. See full safety and prescribing information.

Find DEXILANT (dexlansoprazole) dosing information, clinical data, safety data, and Instant Savings Card information. See Important Safety Information and Prescribing Information.

Leukine® (sargramostim) is contraindicated in patients with excessive leukemic myeloid blasts in bone marrow or peripheral blood (≥ 10%), in patients with known hypersensitivity to GM-CSF, yeast derived products or any components of Leukine, and for concomitant use with chemotherapy and radiotherapy. Please see Full Prescribing Information.

View the prescribing information for a newly approved vaccine called SHINGRIX and sign up to be the first to get the latest news and information.

ROZEREM (ramelteon) is approved for adults having trouble falling asleep from insomnia. Ask your doctor about ROZEREM. See Important Safety Information and Prescribing Information.

Official Site from AbbVie Inc. Please see prescribing information for more about the uses, benefits, and risks of VIEKIRA XR™.

Inhaler prescribing information

Official Site from AbbVie Inc. for patients. View Prescribing Information to learn about the uses, benefits and risks of MAVYRET.

Find information for health care professionals about INVEGA® SUSTENNA®. See full safety and Prescribing Information, including boxed WARNING.

Adempas (riociguat). Visit Adempas-US.com to see full safety and prescribing information including boxed warning. Learn about Adempas and the Aim Patient Support Program.

Brisdelle® (paroxetine) is a non-hormonal medication indicated for the treatment of hot flashes in menopause. Read the full Prescribing Information, including Boxed WARNING.

Learn about STIVARGA (regorafenib). Visit STIVARGA-US.com to see full safety and prescribing information, including boxed warning.

Learn about KALETRA® (Iopinavir/ritonavir). Official site from AbbVie Inc. Includes safety and prescribing information.

DUPIXENT® is for your adult patients with uncontrolled moderate-to-severe atopic dermatitis. Learn more now. Please see Prescribing Information and Important Safety Information on website.

Official HCP site for SYMBICORT, an asthma and COPD treatment, providing information on the inhaler, side effects, dosage and prescribing information.

Official website for Collagenase SANTYL Ointment. See complete Safety and Prescribing Information on this page.

Product information on treatment with DEXILANT (dexlansoprazole) and resources to help you understand and manage your condition. See full safety and prescribing information.

CINQAIR® (reslizumab) Injection is now approved as an add-on treatment for adults (18 years and older) with severe asthma and elevated eosinophil levels

Visit the official site for PRIALT. See safety & Prescribing Information, including Warning about possible serious side effects.

Learn about Vraylar (cariprazine) for acute manic/mixed episodes of Bipolar I disorder & schizophrenia in adults. See risk info, including Boxed Warning & full Prescribing Information.

REXULTI is an add-on treatment for adults with major depressive disorder. See Important Safety Information and Full Prescribing Information, including Boxed WARNING.

Please see Important Safety Information and full Prescribing Information, including Boxed Warning, and Medication Guide.

Learn more about single-bolus TNKase® (tenecteplase) acute myocardial infarction treatment and the 5-second TNKase® dosing and administration. Indication For use in mortality reduction associated with acute myocardial infarction (AMI). Treatment should be initiated as soon as possible after the onset of AMI symptoms. Important Safety Information TNKase therapy in patients with acute myocardial infarction is contraindicated in the following certain situations (eg, active internal bleeding, history of cerebrovascular accident, known bleeding diathesis, severe uncontrolled hypertension) because of an increased risk of bleeding [See CONTRAINDICATIONS in full prescribing information]. The most common complication encountered during TNKase therapy is bleeding. Should serious bleeding (not controlled by local pressure) occur, any concomitant heparin or antiplatelet agents should be discontinued immediately. In certain conditions (eg, recent major surgery, cerebrovascular disease, hypertension) the risk of TNKase therapy may be increased and should be weighed against the anticipated benefits. [See WARNINGS in full prescribing information]. Cholesterol embolism has been reported rarely in patients treated with all types of thrombolytic agents; the true incidence is unknown. Coronary thrombolysis may result in arrhythmias associated with reperfusion. It is recommended that anti-arrhythmic therapy for bradycardia and/or ventricular irritability be available when TNKase is administered. Please see full Prescribing Information for additional important safety information.

See full Prescribing Information including BOXED Warning. Healthcare professional information about VYXEOS™ (daunorubicin and cytarabine).

Register for the Janssen CarePath Support Program to find valuable cost and savings information. See full Prescribing & Safety Info including Boxed Warnings.

Learn more about VIIBRYD® for the treatment of MDD in adults. See safety info, including Boxed Warning & full Prescribing Information.

Do You Or Anyone You Know Wake Up Each Day With A Sore Jaw? Are You Grinding Away Your Teeth? Is Your Dentist Prescribing Costly Mouth Guards To Protect Your Teeth But You Continue Suffering From The Pain? We've Invented A CURE For Bruxism (Teeth Grinding) Which Affects 1 Out Of 10 Adults. But We Need Your Help To Launch Our Product.

FETZIMA® is FDA approved for the treatment of Major Depressive Disorder in adults. See risk info, including Boxed Warning & full Prescribing Information.

Learn about DALVANCE® and how it can help change the ABSSSI treatment journey. See Full Prescribing & Safety Information.

Access exclusive BOTOX® training resources and learn about BOTOX® indications. See full safety and Prescribing Information including Boxed Warning.

Once-daily Tresiba® is a long-acting insulin used to control high blood sugar in adults and children as young as 1 year old with diabetes. Read important safety and prescribing info on this page.

PENNSAID (diclofenac sodium topical solution) official site. Click to see full safety and prescribing information, including boxed warning.

Electronic ordering, referral and fulfillment of patients' medical equipment, products and care services. Electronic ordering, referral and fulfillment of home and durable medical equipment and supplies. Interoperable, EHR integrated and web-based electronic ordering and prescribing solutions.

Healthcare professionals can learn about Orbactiv® (oritavancin) including safety and side effects, benefits and risks, and full prescribing information.

The official ADVATE [Antihemophilic Factor (Recombinant)] site for U.S. healthcare professionals. See Detailed Important Risk Information and full Prescribing Information.

PrescQIPP - We are an NHS funded not-for-profit organisation that supports quality, optimised prescribing for patients. We produce evidence-based resources and tools for primary care commissioners, and provide a platform to share innovation across the NHS.

Reconstitute and administer RYANODEX in less than 1 minute for the management of malignant hyperthermia. See full safety and prescribing information.

Find Important Safety Information and full Prescribing Information, including boxed warning for SUBLOCADE™ (buprenorphine extended-release) here. Sign up for product information and download the press release.

Find healthcare provider information about BIKTARVY® (bictegravir, emtricitabine, tenofovir alafenamide). View full Prescribing Information, including BOXED WARNING.

TRELSTAR® (triptorelin pamoate for injectable suspension) is a palliative treatment for men with advanced prostate cancer. View Important Safety Information and full Prescribing Information on website. Learn more about Trelstar®’s MOA, efficacy, dosing, and administration.

Xeomin® (incobotulinumtoxinA). Official Site. Learn more about XEOMIN. Click to see full Prescribing Information, including Boxed WARNING.

Find TRINTELLIX (vortioxetine) dosing information, clinical study results, safety data, clinical pharmacology and savings information. See Important Safety Information and Prescribing Information.

Learn about RISPERDAL® CONSTA® (risperidone) and how it can help those living with Bipolar I Disorder. See Safety & full Prescribing Information.

The official site for ADYNOVATE. Please see ADYNOVATE Detailed Important Risk Information and full Prescribing Information.

Minivelle (estradiol transdermal system) is indicated for the treatment of hot flashes in menopause. Read the full Prescribing Information, including Boxed WARNING.

DocuTrac offers easy-to-use software for mental health, behavioral health, and substance abuse agencies including billing, e-prescribing, certified electronic health records, electronic medical records, and more

Learn about UTIBRON™ NEOHALER® (indacaterol/glycopyrrolate), indicated for COPD treatment. See Full Prescribing and Safety Info & BOXED WARNING.

Learn about VIIBRYD®, and how it may help you manage your condition. See risk info, including Boxed Warning & full Prescribing Information.

Learn about SILENOR® (doxepin), a nonscheduled prescription sleep aid for the treatment of insomnia characterized by difficulty with sleep maintenance. See safety info & full prescribing information.

Jardiance is the only FDA approved Type 2 Diabetes medication indicated to reduce the risk of Cardiovascular (CV) Death in adult patients with established CV disease. See Important Safety Information and Prescribing Information, including Patient Information.

Myezpharmacy provides complete pharmacy solutions with pharmacy POS system & 24 hour services for healthcare solutions with advanced technology that useful for physicians and pharmacist

Learn about moderate to severe plaque psoriasis & active psoriatic arthritis treatment STELARA®. See Full Prescribing Info & Important Safety Information.

Learn about HEMLIBRA® (emicizumab-kxwh), a hemophilia A treatment now approved for people with hemophilia A with factor VIII inhibitors. See BOXED WARNING. What is HEMLIBRA? HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children with hemophilia A with factor VIII inhibitors. What is the most important information I should know about HEMLIBRA? HEMLIBRA increases the potential for your blood to clot. Discontinue prophylactic use of bypassing agents the day before starting HEMLIBRA prophylaxis. Carefully follow your healthcare provider’s instructions regarding when to use an on-demand bypassing agent, and the dose and schedule you should use. HEMLIBRA may cause the following serious side effects when used with aPCC (FEIBA®), including: Thrombotic microangiopathy (TMA). This is a condition involving blood clots and injury to small blood vessels that may cause harm to your kidneys, brain, and other organs. Get medical help right away if you have any of the signs and symptoms of TMA during or after treatment with HEMLIBRA. Blood clots (thrombotic events). Blood clots may form in blood vessels in your arm, leg, lung or head. Get medical help right away if you have any of the signs or symptoms of blood clots during or after treatment with HEMLIBRA. If aPCC (FEIBA®) is needed, talk to your healthcare provider in case you feel you need more than 100 U/kg of aPCC (FEIBA®) total. How should I use Hemlibra? See the detailed “Instructions for Use” that comes with your HEMLIBRA for information on how to prepare and inject a dose of HEMLIBRA, and how to properly throw away (dispose of) used needles and syringes. HEMLIBRA may interfere with laboratory tests that measure how well your blood is clotting and may cause a false reading. Talk to your healthcare provider about how this may affect your care. What are the other possible side effects of HEMLIBRA? The most common side effects of HEMLIBRA include: redness, tenderness, warmth, or itching at the site of injection; headache; and joint pain. These are not all of the possible side effects of HEMLIBRA. You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. Please see the HEMLIBRA full Prescribing Information and Medication Guide for more important safety information including Serious Side Effects.

Official site for COPAXONE® (glatiramer acetate injection) from Teva. Includes use, safety, prescribing information and patient resources.

See the prescribing information for AZILECT® (rasagiline tablets).

Discover Butrans, a Schedule III, extended-release opioid. See Full Prescribing Info, Safety Info & Boxed Warning.

Calculates ASCVD risk for heart disease and stroke using the 2013 ACC/AHA guidelines. Also incorporates JNC-8 blood pressure guidelines and USPSTF aspirin prescribing guidelines.

Discover prescription TOPAMAX® (topiramate) for migraine prevention in adults and find a coupon. See Important Safety Information & full Prescribing Information.

Learn about Xultophy® 100/3.6, basal insulin & GLP-1 in one injection. Read Important Safety Information & Prescribing Information, including Boxed Warning.

Learn about COUMADIN®, a prescription medicine. Read Important Safety Information and access Prescribing Information including BOXED WARNING and Medication Guide.

The ORENCIA® (abatacept) site provides Important Safety Information and Full Prescribing Information. Visit orencia.bmscustomerconnect.com to learn more

ABILIFY MAINTENA for the treatment of schizophrenia and the maintenance treatment of bipolar I disorder in adult patients. See full Safety and Prescribing Information, including BOXED WARNING.

Ehealth Global is cloud based telemedicine software providing e-prescribing, pharmacy software systems, retail pharmacy software, remote medical access, and private virtual clinics.

BiDil is a prescription medicine used to treat heart failure (HF)… See important safety info & prescribing info.

BAXDELA (delafloxacin) is an FDA approved medication. See important safety & prescribing information, including BOXED WARNING and patient medication guide.

Find information for healthcare professionals about Rituxan® (rituximab), the only FDA-approved treatment proven to induce remission in patients with GPA and MPA. INDICATION STATEMENT - Rituxan® (rituximab), in combination with glucocorticoids, is indicated for the treatment of adult patients with Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA) - Limitations of Use: Rituxan is not recommended for use in patients with severe, active infections BOXED WARNINGS and Additional Important Safety Information BOXED WARNINGS Infusion Reactions: Rituxan administration can result in serious, including fatal, infusion reactions. Deaths within 24 hours of Rituxan infusion have occurred. Approximately 80% of fatal infusion reactions occurred in association with the first infusion. Monitor patients closely. Discontinue Rituxan infusion for severe reactions and provide medical treatment for Grade 3 or 4 infusion reactions. Severe Mucocutaneous Reactions: Severe, including fatal, mucocutaneous reactions can occur in patients receiving Rituxan. Hepatitis B Virus (HBV) Reactivation: HBV reactivation can occur in patients treated with Rituxan, in some cases resulting in fulminant hepatitis, hepatic failure, and death. Screen all patients for HBV infection before treatment initiation, and monitor patients during and after treatment with Rituxan. Discontinue Rituxan and concomitant medications in the event of HBV reactivation. Progressive Multifocal Leukoencephalopathy (PML): PML, including fatal PML, can occur in patients receiving Rituxan. Warnings and Precautions Rituxan administration can also result in additional serious, including fatal, adverse reactions including: - Tumor lysis syndrome (TLS): Administer aggressive intravenous hydration, anti‑hyperuricemic agents, monitor renal function - Infections: Withhold Rituxan and institute appropriate anti-infective therapy - Cardiac arrhythmias and angina: Discontinue infusions in case of serious or life-threatening events - Bowel obstruction and perforation: Consider and evaluate for abdominal pain, vomiting, or related symptoms - Live virus vaccines: Do not administer live virus vaccines prior to or during Rituxan - Cytopenias: Monitor blood counts at regular intervals Granulomatosis With Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA) - Use of concomitant immunosuppressants other than corticosteroids has not been studied in GPA or MPA patients exhibiting peripheral B-cell depletion following treatment with Rituxan. Observe patients with GPA and MPA closely for signs of infection if immunosuppressants other than corticosteroids are used concomitantly - The safety and efficacy of retreatment with Rituxan have not been established in patients with GPA and MPA - Common adverse reactions (≥15%) in the clinical study were infections, nausea, diarrhea, headache, muscle spasms, anemia, and peripheral edema. Other important adverse reactions include infusion reactions You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. For additional safety information, please see the Rituxan full prescribing information, including BOXED WARNINGS.

The Interactive Health Partner is a comprehensive set of health management tools for prescribing, tracking, and monitoring members' health & fitness activity.

Our HIPAA compliant and secure Web Portal offers prescribing physicians online access to patients' sleep test raw data, scoring by registered polysomnographic technologists, and professional interpretation with treatment recommendations by board-certified sleep physicians.